|
NOM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.351080E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.81530000000452E-05 |
| Normal-vs-Stage2 |
1.002300E-02 |
| Normal-vs-Stage3 |
1.736740E-03 |
| Normal-vs-Stage4 |
6.542400E-03 |
| Stage1-vs-Stage2 |
7.837000E-01 |
| Stage1-vs-Stage3 |
8.819600E-01 |
| Stage1-vs-Stage4 |
7.583200E-01 |
| Stage2-vs-Stage3 |
8.932800E-01 |
| Stage2-vs-Stage4 |
9.874200E-01 |
| Stage3-vs-Stage4 |
8.735800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.234600E-04 |
| Normal-vs-AfricanAmerican |
9.587700E-02 |
| Normal-vs-Asian |
1.454060E-02 |
| Caucasian-vs-AfricanAmerican |
5.061000E-01 |
| Caucasian-vs-Asian |
7.505200E-01 |
| AfricanAmerican-vs-Asian |
6.811800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.92420000000504E-05 |
| Normal-vs-Female |
5.360500E-04 |
| Male-vs-Female |
2.248000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.609500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.802900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.363100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.730400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.609800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.647800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.456000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.615600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.090600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.271600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.114500E-02 |
| Classical-VS-Follicular |
1.85019999998648E-06 |
| Classical-VS-Other |
2.365000E-01 |
| Classical-VS-Normal |
9.742300E-03 |
| Tall-VS-Follicular |
2.293600E-01 |
| Tall-VS-Other |
7.623600E-01 |
| Tall-VS-Normal |
1.862330E-03 |
| Follicular-VS-Other |
7.152600E-01 |
| Follicular-VS-Normal |
1.29130000026123E-07 |
| Other-VS-Normal |
3.417600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06250000000163E-05 |
| Normal-vs-N1 |
1.918430E-02 |
| N0-vs-N1 |
2.487800E-01 |
|
|
